Search results
Surprising Health Conditions Our Favorite Celebs Struggle With
Cheapism via AOL· 6 days agoRobin L Marshall / Stringer / Getty Images Ashton Kutcher Condition: Vasculitis In a sneak peek for...
argenx (NASDAQ:ARGX) Posts Earnings Results, Misses Expectations By $0.33 EPS
ETF DAILY NEWS· 4 days agoargenx (NASDAQ:ARGX – Get Free Report) released its earnings results on Thursday. The company reported ($1.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.71) by ($0.33 ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days ago$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024 Management to host conference
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis...
Why Obstetric, Autoimmune History Matter for Women's CV Risk
Medscape· 6 days agoSystemic autoimmune disease is well-recognized as a major risk factor for cardiovascular disease...
Diagnosing Multiple Sclerosis: 5 Things to Know
Medscape· 6 days agoIn the United States, nearly 1 million people are living with multiple sclerosis (MS), an immune-mediated inflammatory disease that causes demyelination...
argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoargenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript May 9, 2024 argenx SE isn’t one of the 30...
Singer Cher Agrees to 'Pause' Fight to Place Troubled Son Elijah Allman Under Conservatorship After...
RadarOnline.com· 19 hours agoSinger Cher and her son Elijah Blue Allman have agreed to pump the brakes on their nasty court battle — only weeks after he asked a court to shut down his famous mother from obtaining his medical ...
Leerink Partnrs Weighs in on InflaRx’s FY2024 Earnings (NASDAQ:IFRX)
ETF DAILY NEWS· 2 days agoInflaRx (NASDAQ:IFRX – Free Report) – Analysts at Leerink Partnrs boosted their FY2024 earnings per share estimates for InflaRx in a research report issued on Wednesday, May 8th. Leerink Partnrs ...